1. Home
  2. YSS vs EWTX Comparison

YSS vs EWTX Comparison

Compare YSS & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo York Space Systems Inc. Common Stock

YSS

York Space Systems Inc. Common Stock

N/A

Current Price

$16.91

Market Cap

2.4B

Sector

Industrials

ML Signal

N/A

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$40.63

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YSS
EWTX
Founded
2012
2017
Country
United States
United States
Employees
710
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
3.7B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
YSS
EWTX
Price
$16.91
$40.63
Analyst Decision
Strong Buy
Buy
Analyst Count
9
6
Target Price
$36.56
$39.00
AVG Volume (30 Days)
1.1M
1.1M
Earning Date
03-19-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$48.43
N/A
Revenue Next Year
$52.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.93
$12.31
52 Week High
$44.54
$48.40

Technical Indicators

Market Signals
Indicator
YSS
EWTX
Relative Strength Index (RSI) 31.61 52.30
Support Level N/A $37.81
Resistance Level $35.56 $43.93
Average True Range (ATR) 1.74 2.69
MACD -0.13 -0.52
Stochastic Oscillator 1.91 29.06

Price Performance

Historical Comparison
YSS
EWTX

About YSS York Space Systems Inc. Common Stock

York Space Systems Inc is a U.S.-based space and defense company that provides mission-related solutions for national security, government, and commercial customers. The company develops its own hardware and software, offering capabilities intended to support customer requirements across various elements of the space mission lifecycle. It offers mission solutions across several complementary product categories: Components, Subsystems, Spacecraft Platforms, Ground Operation, Global Downlink, and Software-Enabled Services. The company derives the majority of revenue from long-term firm-fixed-price (FFP) production contracts for the design of small satellites, launch services, and ground services with both U.S. federal government-controlled agencies and domestic commercial customers.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Share on Social Networks: